Table 3.

Methods for management of urinary and bowel symptoms

Pharmacological interventionsa			Non-pharmacological interventions		Lifestyle modifications
Constipation/bowel supplementsc	Fiber supplements Laxatives Linaclotide Loperamide Lubiprostone Probiotics	42.6%	Leak protection pads/briefse	41.6%	Restricting caffeine and/or alcohol intakeb,e	40.4%
Anti-cholinergicsd	Darifenacin Fesoterodine Oxybutynin Solifenacin Tolterodine Trospium	19.7%	Catheterizationd	13.3%	Limiting/modifying fluid intakee	37.1%
β3-agonistsd	Mirabegron	12.7%	Abdominal massageb,e	9.6%	Limiting/modifying food intakee	23.6%
α-blockersd	Alfuzosin Silodosin Tamsulosin Terazosin	11.3%	Pelvic floor physical therapye	7.9%	Planning daily schedule around proximity to restroomb,e	17.3%
Cholinergic agonistsd	Bethanechol	1.4%

Percentage of patients in our cohort that had tried each medication, non-pharmacological intervention, and lifestyle modification to manage urinary and bowel symptoms

^aAmong patients with a medication record available

^bAmong survey respondents only

^cAmong patients with at least one bowel symptom

^dAmong patients with at least one urinary symptom

^eAmong patients with at least one urinary or bowel symptom